Navigation Links
Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
Date:1/6/2009

KING OF PRUSSIA, Pa., Jan. 6 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that Dr. Warren D. Cooper, President and Chief Executive Officer, will present at the 27th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2009 at 7:30 a.m. (Pacific Time) or 10:30 a.m. (Eastern Time). The conference will be held at the Westin St. Francis Hotel in San Francisco, California.

Dr. Cooper will present corporate strategy and highlight the recent FDA approval of the Company's new drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, a novel, patent-protected, cosolvent free formulation of the antiarrhythmic agent Amiodarone IV.

The presentation will be webcast live by visiting the Company's website at http://www.prismpharma.com. An archive of the presentation also will be available on the Company's website following the conference.

About Prism Pharmaceuticals

Prism Pharmaceuticals, based in King of Prussia, Pennsylvania, is a specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products. The product portfolio strategy is focused on recognizing unfulfilled opportunities in existing compounds that address current unmet medical needs with a specific focus on medication safety in the hospital environment.

For further information, visit http://www.prismpharma.com.


'/>"/>
SOURCE Prism Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
2. Prism glasses expand the view for patients with hemianopia
3. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
4. Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
5. AUDIO from Medialink and Solvay Pharmaceuticals: New Initiative Urges Women to Address Mens Health this New Year
6. Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
7. Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
8. Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
9. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
10. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
11. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: